Natus Medical Operating Expenses Trend

Natus Medical Incorporated -- USA Stock  

USD 39.15  0.2  0.51%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Operating Expenses of Natus Medical Incorporated with missing and latest data points interpolated. Operating expenses represents the total expenditure on Selling General and Administrative Expense, Research and Development Expense and other operating expense items, it excludes Cost of Revenue.
Operating Expenses  10 Years Trend  
Increasing
Slightly volatile
 Operating Expenses 
      Timeline 

Natus Medical Operating Expenses Over Time

2015-12-31  176,900,000 
2016-12-31  182,000,000 
2017-12-31  188,894,737 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  128,562,145
Geometric Mean  111,332,405
Coefficient Of Variation  43.74
Mean Deviation  48,309,787
Median  158,214,000
Standard Deviation  56,233,462
Range  167,514,737
R Value  0.96
R Squared  0.92
Significance  0.00000074
Slope  14,974,997

Currently Trending

S   
 NYQ 
Purchased over 400 shares of
a day ago ago
Traded for 7.12
GM   
 NYQ 
Purchased over 60 shares of
a day ago ago
Traded for 45.88
MSFT   
 NMS 
Purchased over 30 shares of
a day ago ago
Traded for 77.49